Evidence map›Paper›PMID 26607656›Full record

ArticleScientific reports2015

Genetic polymorphisms of PCSK2 are associated with glucose homeostasis and progression to type 2 diabetes in a Chinese population.

Tien-Jyun Chang, Yen-Feng Chiu, Wayne H-H Sheu, Kuang-Chung Shih, Chii-Min Hwu, Thomas Quertermous, Yuh-Shan Jou, Shan-Shan Kuo, Yi-Cheng Chang, Lee-Ming Chuang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Tien-Jyun ChangDepartment of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan.
Yen-Feng ChiuDepartment of Bioinformatics and Biostatistics, National Health Research Institutes, Zhunan Town, Miaoli County 35053, Taiwan.
Wayne H-H SheuDepartment of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Kuang-Chung ShihDivision of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Chii-Min HwuSection of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei 11127, Taiwan.
Thomas QuertermousDivision of Cardiovascular Medicine, Falk Cardiovascular Research Building, Stanford University School of Medicine, Stanford, CA 94305, USA.
Yuh-Shan JouInstitute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
Shan-Shan KuoDepartment of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan.
Yi-Cheng ChangDepartment of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan.
Lee-Ming ChuangDepartment of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan.
National Taiwan University · TWNational Taiwan University Hospital · TWInstitute of Biomedical Sciences, Academia Sinica · TWNational Health Research Institutes · TWNational Yang Ming Chiao Tung University · TWStanford University · USTaichung Veterans General Hospital · TWTaipei Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proprotein convertase subtilisin/kexin type 2 (PCSK2) is a prohormone processing enzyme involved in insulin and glucagon biosynthesis. We previously found the genetic polymorphism of PCSK2 on chromosome 20 was responsible for the linkage peak of several glucose homeostasis parameters. The aim of this study is to investigate the association between genetic variants of PCSK2 and glucose homeostasis parameters and incident diabetes. Total 1142 Chinese participants were recruited from the Stanford Asia-Pacific Program for Hypertension and Insulin Resistance (SAPPHIRe) family study, and 759 participants were followed up for 5 years. Ten SNPs of the PCSK2 gene were genotyped. Variants of rs6044695 and rs2284912 were associated with fasting plasma glucose, and variants of rs2269023 were associated with fasting plasma glucose and 1-hour plasma glucose during OGTT. Haplotypes of rs4814605/rs1078199 were associated with fasting plasma insulin levels and HOMA-IR. Haplotypes of rs890609/rs2269023 were also associated with fasting plasma glucose, fasting insulin and HOMA-IR. In the longitudinal study, we found individuals carrying TA/AA genotypes of rs6044695 or TC/CC genotypes of rs2284912 had lower incidence of diabetes during the 5-year follow-up. Our results indicated that PCSK2 gene polymorphisms are associated with pleiotropic effects on various traits of glucose homeostasis and incident diabetes.

Indexed as

Disease ProgressionGenetic Predisposition to DiseaseAsian PeopleBlood GlucoseChinaDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGenome-Wide Association StudyHaplotypesHomeostasisHumansIncidenceLinkage DisequilibriumMaleMiddle AgedBlood GlucosePCSK2 protein, humanProprotein Convertase 2

Identifiers

PMID26607656
PMCPMC4660384
OpenAlexW2173215630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.